GILD — GILEAD SCIENCES, INC.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 882095 ·
Last close
$149.05
Market Cap
$184.82B
52W High
$154.51
52W Low
$105.84
ADV30
5,800,201
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 6,960,000,000 | 5,515,000,000 | 2,692,000,000 | 2,021,000,000 | 56,278,000,000 | 7,628,000,000 | 32,847,000,000 |
| Dec 2025 | 7,924,000,000 | 6,300,000,000 | 2,988,000,000 | 2,183,000,000 | 59,023,000,000 | 7,564,000,000 | 36,405,000,000 |
| Sep 2025 | 7,769,000,000 | 6,200,000,000 | 3,497,000,000 | 3,052,000,000 | 58,533,000,000 | 7,330,000,000 | 37,077,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$10,805,000,000
Investing CF
$-2,609,000,000
Financing CF
$-8,557,000,000
CapEx
$-576,000,000
Dividends Paid
$-4,033,000,000
Buybacks
$-1,611,000,000
EPS Diluted TTM
$-2.67
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$2,200,000,000
Inventory
$1,953,000,000
Receivables
$5,055,000,000
ST Investments
$0
EBIT TTM
$-957,000,000
Pretax Income TTM
$-1,955,000,000
Interest Exp TTM
$998,000,000
Analysts
27
Yahoo Snapshot (yfinance, live)
Total Revenue
$30,456,999,936
EBITDA
$14,600,999,936
Free Cash Flow
$9,768,875,008
Enterprise Value
$199,486,357,504
Total Cash
$4,881,999,872
Total Debt
$26,246,000,640
Shares Out
1,239,955,155
Trailing EPS
$-2.64
Book Value
$9.53
ROE
-20.7%
ROA
14.1%
Div Yield
2.28%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 29,442,000,000 | 11,701,000,000 | 8,510,000,000 | 59,023,000,000 | 36,405,000,000 | 22,702,000,000 | 10,019,000,000 |
| Dec 2024 | 28,754,000,000 | 10,596,000,000 | 480,000,000 | 58,995,000,000 | 39,749,000,000 | 19,330,000,000 | 10,828,000,000 |
| Dec 2023 | 27,116,000,000 | 8,838,000,000 | 5,665,000,000 | 62,125,000,000 | 39,376,000,000 | 22,833,000,000 | 8,006,000,000 |
| Dec 2022 | 27,281,000,000 | 10,974,000,000 | 4,592,000,000 | 63,171,000,000 | 41,962,000,000 | 21,240,000,000 | 9,072,000,000 |
TTM Snapshot
Revenues TTM
$28,305,000,000
NetIncome TTM
$6,537,000,000
OpCashFlow TTM
$0
Assets (Latest)
$59,023,000,000
Forward EPS
$9.89
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $145.00 · spot: $149.05 · call volume: 252 · put volume: 4,940
Expected Move to 2026-11-20:
±$14.05
(9.43%) —
implied range
$135.00 –
$163.10
· ATM straddle on $150.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $227.88B | $421.51 | — |
| MRNA | Moderna, Inc. | $76.88B | $192.57 | — |
| ARGX | ARGENX SE | $59.63B | $958.91 | — |
| RVMD | Revolution Medicines, Inc. | $43.99B | $205.26 | — |
| BIIB | BIOGEN INC. | $33.37B | $225.88 | — |
News headlines (Yahoo Finance, 1h cache)
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors
2026-09-30 21:00 · Yahoo
CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J
2026-09-30 08:47 · Yahoo
Former Gilead CIO and CSL Chief Digital & Information Officer Mark Hill Joins Sware Board of Directors
2026-09-29 13:00 · Yahoo
Small Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & Pfizer
2026-09-29 09:22 · Yahoo
Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase?
2026-09-28 23:52 · Yahoo
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing?
2026-09-28 18:45 · Yahoo
Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?
2026-09-28 18:08 · Yahoo
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend?
2026-09-28 13:11 · Yahoo
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income?
2026-09-27 23:20 · Yahoo
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
2026-09-27 23:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.